COVID19 Infection: Clinical Trials

2 trials for COVID19 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow COVID19 Infection: new trials by email Literature Review of COVID19 Infection trials Research Report on COVID19 Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
Cyclosporine, Standard treatment - COVID19 Infection
Phase 4CompletedInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz1112020-04-162022-07-14
Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
Sevoflurane, Propofol - Acute Respiratory Distress Syndrome, COVID19 Infection
Phase 4TerminatedFundación para la Investigación del Hospital Clínico de Valencia192020-04-162021-07-27

Narrower conditions

COVID-19 (2)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Respiration Disorders (1)

Interventions

Cyclosporine (1)  ·  Propofol (1)  ·  Sevoflurane (1)

Sponsors

Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)

Countries

Spain (2)

Top investigators

Olga Sanchez Pernaute, MD, PhD (1)